Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel T Wilkinson

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
The Journal of Clinical Psychiatry|April 22, 2020
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)Ewa Wajs, Leah Aluisio, Richard Holder, et al.
The New England Journal of Medicine|May 24, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major DepressionAmit Anand, Sanjay J Mathew, Gerard Sanacora, et al.
Molecular Psychiatry|September 7, 2022
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderatorsRebecca B Price, Nicholas Kissel, Andrew Baumeister, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
The Journal of Clinical Psychiatry|April 22, 2020
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)Ewa Wajs, Leah Aluisio, Richard Holder, et al.
The New England Journal of Medicine|May 24, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major DepressionAmit Anand, Sanjay J Mathew, Gerard Sanacora, et al.
Molecular Psychiatry|September 7, 2022
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderatorsRebecca B Price, Nicholas Kissel, Andrew Baumeister, et al.
Pageof 11